XML 66 R37.htm IDEA: XBRL DOCUMENT v3.22.4
STOCK COMPENSATION (Tables)
 12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Share-based Payment Arrangement, Cost by Plan
The amounts of stock compensation expense recorded in the Company's Consolidated Statements of Operations for the years ended December 31, 2022, 2021 and 2020 were as follows:
Year Ended December 31,
(in millions)202220212020
Cost of products sold$3 $3 $1 
Selling, general, and administrative expense53 44 44 
Research and development expense3 2 1 
Total stock based compensation expense$59 $49 $46 
Related deferred income tax benefit$7 $6 $5 
Schedule of Assumptions Used to Determine Compensation Cost for the Company's Non-qualified Stock Options Issued
The Company uses the Black-Scholes option-pricing model to estimate the fair value of each option awarded. The average assumptions used to determine compensation cost for the Company’s NQSOs issued were as follows:
Year Ended December 31,
 202220212020
Weighted average fair value per share$14.06   $15.90   $10.03   
Expected dividend yield1.09 %0.68 %0.84 %
Risk-free interest rate2.23 %0.79 %0.77 %
Expected volatility32.7 %31.5 %24.0 %
Expected life (years)5.205.085.49
Schedule of Non-qualified Stock Option Transactions The NQSO transactions for the year ended December 31, 2022 were as follows:
 OutstandingExercisableExpected to Vest
(in millions, except per share amounts)Shares
Weighted
Average
Exercise
Price
Aggregate
Intrinsic
Value
Shares
Weighted
Average
Exercise
Price
Aggregate
Intrinsic
Value
SharesWeighted
Average
Exercise
Price		Aggregate
Intrinsic
Value
December 31, 20213.2 $52.44 $15 2.2 $52.05 $11 1.0 $53.29 $4 
Granted0.8 48.18     
Exercised(0.2)42.57     
Cancelled(0.5)53.53 
Forfeited(0.3)53.42     
December 31, 20223.0 $51.64 $— 1.9 $52.43 $— 1.1 $50.21 $— 
Schedule of Information about Non-qualified Stock Options Outstanding
Information about NQSOs outstanding for the year ended December 31, 2022 were as follows:
 OutstandingExercisable
Number
Outstanding
at
December 31, 2022
Weighted
Average
Remaining
Contractual
Life
(in years)
Weighted
Average
Exercise
Price
Number
Exercisable
at
December 31, 2022
Weighted
Average
Exercise
Price
Range of Exercise Prices
(in millions, except per share amounts and life)
30.01 -40.000.2 9.3$31.35 — $37.22 
40.01 -50.001.1 4.847.09 0.9 46.98 
50.01 -60.001.4 6.555.47 0.7 55.78 
60.01 -70.000.3 3.662.34 0.3 62.26 
 3.0 1.9 
Schedule of the Unvested RSU Transactions The unvested RSU transactions for the year ended December 31, 2022 were as follows:
 Unvested Restricted Stock Units
 Shares
Weighted Average
Grant Date
Fair Value
(in millions, except per share amounts)
Unvested at December 31, 2021
3.1 $53.52 
Granted3.3 39.73 
Vested(1.0)37.76 
Forfeited(1.0)42.31 
Unvested at December 31, 2022
4.4 $45.63